Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Pract Radiat Oncol. 2019 Feb 27;9(4):e386–e393. doi: 10.1016/j.prro.2019.02.013

Table 2:

Radiation Therapy Plan Central Review

Level II
(4.0 Gy/fx)
(n=8)
Level III
(4.5 Gy/fx)
(n=7)
Level IV
(5.0 Gy/fx)
(n=8)
Tumor volume contouring score
 Per protocol 7 (87.5%) 7 (100.0%) 6 (75.0%)
 Acceptable variation 1 (12.5%) 0 (0.0%) 2 (25.0%)
 Unacceptable variation 0 (0.0%) 0 (0.0%) 0 (0.0%)
Organs at risk contouring score
 Per protocol 8 (100.0%) 6 (85.7%) 6 (75.0%)
 Acceptable variation 0 (0.0%) 0 (0.0%) 1 (12.5%)
 Unacceptable variation 0 (0.0%) 1a (14.3%) 1b (12.5%)
Tumor volume dose score
 Per protocol 8 (100.0%) 6 (85.7%) 5 (62.5%)
 Acceptable variation 0 (0.0%) 0 (0.0%) 0 (0.0%)
 Unacceptable variation 0 (0.0%) 1a (14.3%) 3c,d,e (37.5%)
Organs at risk dose score
 Per protocol 8 (100.0%) 6 (85.7%) 8 (100.0%)
 Acceptable variation 0 (0.0%) 0 (0.0%) 0 (0.0%)
 Unacceptable variation 0 (0.0%) 1a (14.3%) 0 (0.0%)

Abbreviations: Gy, Gray; fx, fraction

a

No small bowel contour; maximum dose was slightly high; and the liver dose was too high.

b

No small bowel contour.

c,d,e

Liver dose was too high; another patient did not have IV contrast so the gross tumor target volume could not be assessed accurately; one patient had one lesion treated to 35 Gy (not evaluated for protocol) and another to 50 Gy.